ADC Therapeutics SA (ADCT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov11

RBC Analyst Maintains Buy Rating and Target Price for ADC Therapeutics

12:31

Nov10

ADC Therapeutics SA released FY2025 9 Months Earnings on November 10 Pre-Market EST, Actual Revenue: USD 58.3 M, Actual EPS: USD -1.1583

14:30

ADC Therapeutics SA released FY2025 Q3 earnings on November 10 Pre-Market EST, actual revenue USD 16.43 M (forecast USD 16.79 M), actual EPS USD -0.3002 (forecast USD -0.3616)

14:30

Nov3

ADC Therapeutics SA to Release FY2025 Q3 Earnings on November 10, 2025 Pre-Market EST, Forecast Revenue USD 17.08 M, EPS USD -0.38

00:07

Oct13

ADC Therapeutics Unveils Expansion Plan for ZYNLONTA

11:54

Oct8

Schmidt Maintains Buy Rating on ADC Therapeutics Stock

11:02

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 16.43 M, Net Income -40.97 M, EPS -0.3002

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 18.84 M, Net Income -56.65 M, EPS -0.498

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 23.03 M, Net Income -38.6 M, EPS -0.36

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change